SWISS PORTFOLIO UPDATE
(July 11, 2025)
Portfolio Performance
The results speak for themselves. Over the past 12 months (ending July 11, 2025) our portfolio has gained +54.57%. By comparison, the S&P 500 returned only about +11% over the same period. This roughly 5x outperformance underscores that our concentrated, research-driven approach is yielding substantial alpha. The performance chart below visualizes our cumulative return vs the S&P 500. We view this as validation of the strategy, but we also remain cautious. The Swiss Portfolio goal is simple: to keep compounding at a high rate, consistently above the market, while transparently sharing all progress (and setbacks) with our members.
Index:
Transparency & Skin in the Game
Top 8 Holdings Recap
Portfolio Allocation & Structure
Strategy & Positioning Update
Bonus: Excel S&P Tracking Template
Transparency & Skin in the Game
In finance, credibility is everything. Too often we read bullish market commentary from analysts who never show their cards, no portfolio disclosures, no real “skin in the game”, all while charging three-figure annual memberships or selling courses. At Swiss Portfolio, we think differently. We show our cards. Every month, we publish a full portfolio update, sharing exactly where our capital is deployed and, more importantly why. And we do it for a symbolic $39.99 annual fee, just enough to keep the knowledge flowing and the communication lines open for our members. From our point of view, offering more value and transparency at a fraction of the cost of most three-figure memberships.
Our allocation snapshot (see next chapter) reflects that philosophy in action. Two of our earliest deep dives, $PSIX and $IESC, have evolved into concentrated bets within a deliberately concentrated portfolio. We’ll break down the full structure in the next chapter, but suffice it to say: we don't just write about high-conviction ideas, we back them, visibly and publicly. This is real skin in the game. At Swiss Portfolio, we practice what we preach.
Top 8 Holdings Recap
#8 AMD (2.26% allocation): We took advantage of the April dip to initiate our position in Advanced Micro Devices, benefiting from what we viewed as highly discounted prices. AMD remains our core AI-chip play. While the stock has had its ups and downs, the company continues to make steady progress. In June 2025, AMD hosted its “Advancing AI” conference, unveiling the new MI300-series GPUs and its “Helios” AI server platform for 2026. Notably, OpenAI’s CEO announced that ChatGPT will adopt AMD’s upcoming MI450 chips, an important validation of AMD’s trajectory. These developments, combined with AMD’s growing open-source ecosystem, particularly its collaboration with $META, reinforce that the company is building credible AI infrastructure. We believe it remains a strong player for the next chapters in the AI race, particularly as inference workloads begin to scale meaningfully between H2 2025 and 2026. We're also confident in the leadership of one of the most capable CEOs: Lisa Su.
Her track record of execution and vision gives us additional conviction in AMD’s roadmap. Only best-in-class leaders can deliver this kind of transformation, a 70x stock over two decades, the result of disciplined innovation, strategic focus, and world-class capital allocation, in one of the trickiest and most competitive sectors on earth.
#7 AMZN (2.32% allocation): Amazon may surprise some as one of our top 8, but remember, it’s not just an e-commerce king, it’s also a robotics and AI powerhouse. We don’t usually like citing data from others, especially ARK Invest, often known for participating in late-stage bull market peaks. But in this case, we believe the trend is directionally right: by 2025, Amazon is projected to have around 1 million robots supporting approximately 1,5 million employees. In other words, Amazon is on track to become the world’s largest robotics company.
This level of automation across warehouses, logistics, and AWS data centers gives Amazon a durable structural moat. In our view, it is one of the best-positioned companies to benefit from AI commoditization: the largest robotic workforce, unmatched ad-to-cart conversion efficiency, and a $2.4 trillion company that still operates with a Day 1 startup mindset. Just amazing.
#6 HIMS (2.75% allocation): Hims & Hers Health (HIMS) is the telehealth/wellness platform in our portfolio. Since our deep dive, the stock is up ~85%, a testament to execution on its strategy. Recently, HIMS announced an aggressive expansion plan: on July 9, 2025 they revealed a 2026 launch in Canada, timed with the introduction of generic GLP-1 weight-loss drugs, following their acquisition of the European platform ZAVA. This move highlights how Hims is scaling its affordable healthcare offerings globally, particularly in areas like obesity, yes, but Market is underestimating many others. We see this and other recent initiatives as entirely consistent with our original thesis: a best-in-class management team building what could become the most valuable subscription service in preventive healthcare. In an industry as complex and risk-heavy as healthcare, the odds of success are slim, but Hims is proving that top-tier execution can bend the odds.
And the proof? When pharma giants start taking shots at you, you're either doing something very right, (or very wrong). And that’s exactly why our allocation to Hims & Hers remains modest for now. It’s a high-upside, high-risk bet. But it’s also one of the positions we’re ready to increase, either after revalidating the thesis during upcoming earnings calls or if a meaningful price dislocation creates a compelling entry point.
Something Big is coming to Swiss Portfolio
Over the past 12 months, our portfolio returned +54% vs +11% for the S&P 500.
That’s not by chance. It’s the result of deep research, disciplined capital allocation, and a focus on durable, capital-light compounders, with strong management, sector tailwinds, and attractive valuations, often well before they’re widely recognized.
For just $39.99/year, you’ll gain full access to:
✅ Full access to Swiss Portfolio positions + monthly allocation updates.
✅ At least 1 high-conviction deep dive every month.
✅ Downloadable financial models to follow and stress-test each thesis.
✅ Live idea tracking once they spike, plus an S&P tracking template.
✅ Exclusive Swiss-based insights on investing, residence, and tax optimization.
🧠 The $39.99 subscription pays for itself a few times over, sometimes in just one deep dive. This isn’t about hype. It’s about transparency, consistency, and long-term compounding.
If you share our philosophy of identifying scalable compounders in high-quality jurisdictions backed by durable megatrends, we strongly encourage you to explore how past ideas have performed:👇
HIMS +85% since deep dive (13.1)
IESC +34% since deep dive (9.2)
PSIX +131% since deep dive (5.3)
SPGI +8% since deep dive (14.3)
DUOL -7% since deep dive (1.5)
WST +8% since deep dive (22.5)
SGX: BBW +0% since deep dive (9.6)
🫶 A huge thank you to everyone who’s already supporting the project in its early stages, whether through a subscription or the symbolic $39.99 annual fee. Your trust makes this possible and keeps us motivated to continue sharing deep research and strategic thinking over time.
The goal is simple: to consistently beat the S&P 500 through high-conviction investments, executed with discipline, backed by data, and aligned with the Swiss mindset: careful risk, long-term focus and best-in-class quality.
📬 Read us. Join us. Sleep well.📈✨
If this kind of research resonates with you, not just theory, but +40% outperformance, consider going deeper.
For a symbolic $39.99/year, get full access and help support the work behind it. High-conviction research. Real compounders. Tax-optimized strategies.
If that’s your game too, you know where to click. 😉 ⬇️.
Incredible names so far, right? Want to see our Top 5? These are the concentrated bets truly driving Swiss Portfolio performance. Become a member and support our work for just $39.99/year, offering more value and transparency at a fraction of the cost of most three-figure memberships. For our early members, Join in 2025, and we’ll lock you in that price for life.
💥 Special offer until July 31:
Members joining before the deadline will get 15% off for life, that means just $33.99/year, locked in forever. Don’t miss it. Click the button above.
Keep reading with a 7-day free trial
Subscribe to Swiss Transparent Portfolio to keep reading this post and get 7 days of free access to the full post archives.